Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
Multiple sclerosis: Bigger brains resist disability in MS.
The complex role of estrogens in inflammation.
Co-occurrence of multiple sclerosis and Parkinson disease.
Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe.
Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy.
The Efficacy of Functional Electrical Stimulation of the Abdominal Muscles in the Treatment of Chronic Constipation in Patients with Multiple Sclerosis: A Pilot Study.
Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.
Cognitive Impairment and Health Related Quality of Life in Relapsing Remitting Multiple Sclerosis.
Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings.
Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.
Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus.
Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3.
A timing-of-birth effect on multiple sclerosis clinical phenotype.
Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.
[The biological role of sulfatides].
Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.
Mycophenolate Mofetil as a Monotherapy in Multiple Sclerosis: a multicentre retrospective study on 361 patients
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.